These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The HYDILE trial: efficacy and tolerance of a quadruple combination of reverse transcriptase inhibitors versus the same regimen plus hydroxyurea or hydroxyurea and interleukin-2 in HIV-infected patients failing protease inhibitor-based combinations. Lafeuillade A; Hittinger G; Chadapaud S; Maillefet S; Rieu A; Poggi C HIV Clin Trials; 2002; 3(4):263-71. PubMed ID: 12187499 [TBL] [Abstract][Full Text] [Related]
5. A new approach to initial antiretroviral therapy: protease-sparing combination regimens. Hanna L BETA; 1998 Oct; ():9-13. PubMed ID: 11365999 [TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea for HIV infection. Zachary KC; Davis B AIDS Clin Care; 1998 Apr; 10(4):25-6, 32. PubMed ID: 11365149 [TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea in HIV therapy. HIV Hotline; 1998 Mar; 8(1):5-7. PubMed ID: 11365359 [TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial investigating the efficacy and safety of switching from a protease inhibitor to nevirapine in patients with undetectable viral load. Arranz Caso JA; López JC; Santos I; Estrada V; Castilla V; Sanz J; Sanz J; Molina JP; Fernández Guerrero M; Górgolas M HIV Med; 2005 Sep; 6(5):353-9. PubMed ID: 16156884 [TBL] [Abstract][Full Text] [Related]
11. Effects of switching to protease inhibitor monotherapy on nucleoside analogue-related adverse events. Clumeck N; Hill A; Moecklinghoff C AIDS Rev; 2014; 16(4):236-45. PubMed ID: 25350532 [TBL] [Abstract][Full Text] [Related]
12. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E; Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227 [TBL] [Abstract][Full Text] [Related]
13. Antiviral update. PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972 [TBL] [Abstract][Full Text] [Related]
14. Standard treatments for HIV, Spring 1997. Smith D AIDS Treat News; 1997 Apr; (No 269):4-5. PubMed ID: 11364255 [TBL] [Abstract][Full Text] [Related]
15. Delavirdine: a review of its use in HIV infection. Scott LJ; Perry CM Drugs; 2000 Dec; 60(6):1411-44. PubMed ID: 11152019 [TBL] [Abstract][Full Text] [Related]